메뉴 건너뛰기




Volumn 87, Issue 6, 2008, Pages 495-496

Development of thrombotic thrombocytopenic purpura after a single dose of gemcitabine

Author keywords

[No Author keywords available]

Indexed keywords

BILIRUBIN; CREATININE; GEMCITABINE; HAPTOGLOBIN; HEMOGLOBIN; LACTATE DEHYDROGENASE; UREA;

EID: 42549125710     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00277-007-0429-9     Document Type: Letter
Times cited : (24)

References (8)
  • 1
    • 34347209038 scopus 로고    scopus 로고
    • Gemcitabine-associated thrombotic thrombocytopenic purpura
    • Zupancic M, Shah PC, Shah-Khan F (2007) Gemcitabine-associated thrombotic thrombocytopenic purpura. Lancet Oncol 8:634-641
    • (2007) Lancet Oncol , vol.8 , pp. 634-641
    • Zupancic, M.1    Shah, P.C.2    Shah-Khan, F.3
  • 2
    • 15544362071 scopus 로고    scopus 로고
    • Three cases of hemolytic uremic syndrome in ovarian cancer patients treated with combination gemcitabine and pegylated liposomal doxorubicin
    • Lewin SN, Mutch DG, Withcomb BP et al (2005) Three cases of hemolytic uremic syndrome in ovarian cancer patients treated with combination gemcitabine and pegylated liposomal doxorubicin. Gynecol Oncol 97:228-233
    • (2005) Gynecol Oncol , vol.97 , pp. 228-233
    • Lewin, S.N.1    Mutch, D.G.2    Withcomb, B.P.3
  • 3
    • 0036323032 scopus 로고    scopus 로고
    • Hemolytic uremic syndrome after chemotherapy with gemcitabine and taxotere: A case report
    • Citarrella P, Gebbia V, Teresi M et al (2002) Hemolytic uremic syndrome after chemotherapy with gemcitabine and taxotere: A case report. Anticancer Res 22:1183-1185
    • (2002) Anticancer Res , vol.22 , pp. 1183-1185
    • Citarrella, P.1    Gebbia, V.2    Teresi, M.3
  • 4
    • 0038495616 scopus 로고    scopus 로고
    • Gemcitabine and oxaliplatin for metastatic pancreatic adenocarcinoma: A North Central Cancer Treatment Group phase II study
    • Alberts SR, Townley PM, Goldberg RM et al (2003) Gemcitabine and oxaliplatin for metastatic pancreatic adenocarcinoma: A North Central Cancer Treatment Group phase II study. Ann Oncol 14:580-585
    • (2003) Ann Oncol , vol.14 , pp. 580-585
    • Alberts, S.R.1    Townley, P.M.2    Goldberg, R.M.3
  • 5
    • 11844291977 scopus 로고    scopus 로고
    • Hemolytic uremic syndrome following prolonged gemcitabine therapy: Report of four cases from a single institution
    • Muller S, Schutt P, Bojko P et al (2005) Hemolytic uremic syndrome following prolonged gemcitabine therapy: Report of four cases from a single institution. Ann Hematol 84:110-114
    • (2005) Ann Hematol , vol.84 , pp. 110-114
    • Muller, S.1    Schutt, P.2    Bojko, P.3
  • 6
    • 0032569884 scopus 로고    scopus 로고
    • Von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic uremic syndrome
    • Furlan M, Robles R, Galbusera M et al (1998) Von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic uremic syndrome. N Engl J Med 339:1578-1584
    • (1998) N Engl J Med , vol.339 , pp. 1578-1584
    • Furlan, M.1    Robles, R.2    Galbusera, M.3
  • 7
    • 33646360865 scopus 로고    scopus 로고
    • Clinical practice. Thrombotic thrombocytopenic purpura
    • George JN (2006) Clinical practice. Thrombotic thrombocytopenic purpura. N Engl J Med 354:1927-1935
    • (2006) N Engl J Med , vol.354 , pp. 1927-1935
    • George, J.N.1
  • 8
    • 0037968640 scopus 로고    scopus 로고
    • ADAMTS13 activity in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: Relation to presenting features and clinical outcomes in a prospective cohort of 142 patients
    • Vessely SK, George JN, Lammle B et al (2003) ADAMTS13 activity in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: Relation to presenting features and clinical outcomes in a prospective cohort of 142 patients. Blood 102:60-68
    • (2003) Blood , vol.102 , pp. 60-68
    • Vessely, S.K.1    George, J.N.2    Lammle, B.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.